Wanbury Limited Completes TGA Quality Inspection for Andhra Pradesh API Site
Wanbury Limited has successfully completed a quality inspection by the Therapeutic Goods Administration (TGA), the drug regulatory agency of Australia, concerning its API manufacturing site located in Tanuku, Andhra Pradesh.Upon receiving the GMP certificate from the TGA, the successful completion of the inspection will enable Wanbury to ship additional three APIs. The company confirmed that it remains committed to continual improvement and maintains compliance with cGMP standards at the facility.
In addition, updates regarding other facilities show that the API site in Patalganga secured a GMP certificate from MFDS (Korean FDA). This certification was achieved following an inspection conducted in April 2026.
WANBURY Stock Price Movement
As of 12:50 PM, shares of Wanbury Limited are slipping by 0.23% in live trading, currently at ₹265.15 as the company trades below its previous closing level. The equity has seen robust activity, with a volume of 80,298 shares traded so far this session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.